Company intelligence / Profile preview

Google DeepMind

London, England, United Kingdomdeepmind.google ↗

Ownership: Private
Employees: ~700
Development stage: Other

Overview

DeepMind’s AlphaFold system achieved breakthrough accuracy in predicting 3D protein structures—solving a decades-old challenge—which has accelerated biomedical research globally. Its Streams app was piloted with NHS partners for early detection of acute kidney injury and other conditions. No therapeutics have entered clinical trials under the company's name.

Industry: Drug Discovery Services

Partnerships

Royal Free NHS Trust – co-development of Streams app for clinical task managementCancer Research UK Center at Imperial College London – breast cancer detection using machine learningU.S. Department of Veterans Affairs – predicting acute kidney injury using machine learning

Beyond the preview

Go deeper on Google DeepMind.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Google DeepMind.

Explore the full profile